C. R. Bard, Inc.:市場シェア分析...市場調査レポートについてご紹介

【英文タイトル】C. R. Bard, Inc. Market Share Analysis

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 11
1.2 List of Figures 13
2 Introduction 15
2.1 What Is This Report About? 15
3 Definitions of Markets/Categories Covered 16
3.1 Cardiovascular Devices 16
3.1.1 Electrophysiology 16
3.1.2 Peripheral Vascular Devices 16
3.2 Nephrology and Urology Devices 16
3.2.1 Incontinence Devices 16
3.3 Drug Delivery Devices 16
3.3.1 Central Venous Catheters 16
4 Company Snapshot 17
4.1 Key Facts 17
4.2 Company Overview 17
4.3 Financial Performance 17
4.4 SWOT Snapshot 17
5 Business Description 18
5.1 Business Overview 18
5.2 Oncology Product Line 18
5.2.1 Overview 18
5.2.2 Financials 18
5.3 Other Products Product Line 18
5.3.1 Overview 18
5.3.2 Financials 18
5.4 Surgical Specialties Product Line 18
5.4.1 Overview 18
5.4.2 Financials 19
5.5 Urology Product Line 19
5.5.1 Overview 19
5.5.2 Financials 19
5.6 Vascular Product Line 19
5.6.1 Overview 19
5.6.2 Financials 20
5.6.3 Market View 20
5.7 Major Products and Services 20
5.7.1 Overview 20
6 History 22
7 SWOT Analysis 25
7.1 Overview 25
7.2 C. R. Bard, Inc. Strengths 25
7.2.1 Diversified Business Operations 25
7.2.2 Sturdy Research and Development Activities 26
7.2.3 Constant Growth in Revenues 26
7.3 C. R. Bard, Inc. Weaknesses 26
7.3.1 Legal Proceedings and Product Recalls 26
7.3.2 Dependence on the US Market 26
7.4 C. R. Bard, Inc. Opportunities 27
7.4.1 Expansion through Acquisitions 27
7.4.2 Pipeline Clinical Trials 27
7.4.3 Global Nephrology and Urology Devices Market 27
7.5 C. R. Bard, Inc. Threats 28
7.5.1 Stringent Government Regulations 28
7.5.2 Shift in Technology 28
7.5.3 Healthcare Reform Bill 28
8 Competitors 29
9 Competitive Landscape 30
9.1 Cardiovascular Devices (Peripheral Vascular Devices), Global, Market Share (%), 2011 30
9.2 C. R. Bard, Inc., Cardiovascular Devices (Peripheral Vascular Devices), by Region, Market Share (2011) 32
9.3 C. R. Bard, Inc., Cardiovascular Devices (Peripheral Vascular Devices), by Country, Market Share (2011) 33
9.4 Cardiovascular Devices (Electrophysiology), Global, Market Share (%), 2011 35
9.5 C. R. Bard, Inc., Cardiovascular Devices (Electrophysiology), by Region, Market Share (2011) 37
9.6 C. R. Bard, Inc., Cardiovascular Devices (Electrophysiology), by Country, Market Share (2011) 38
9.7 Drug Delivery Devices (Central Venous Catheters), Global, Market Share (%), 2011 40
9.8 C. R. Bard, Inc., Drug Delivery Devices (Central Venous Catheters), by Region, Market Share (2011) 42
9.9 C. R. Bard, Inc., Drug Delivery Devices (Central Venous Catheters), by Country, Market Share (2011) 43
9.10 Nephrology and Urology Devices (Incontinence Devices), Global, Market Share (%), 2011 45
9.11 C. R. Bard, Inc., Nephrology and Urology Devices (Incontinence Devices), by Region, Market Share (2011) 47
9.12 C. R. Bard, Inc., Nephrology and Urology Devices (Incontinence Devices), by Country, Market Share (2011) 48
10 C. R. Bard, Inc. Medical Equipment Market Share Analysis by Category 50
10.1 C. R. Bard, Inc., Global, Category Revenue Share (2011) 50
10.2 C. R. Bard, Inc., Asia-Pacific, Category Revenue Share (2011) 52
10.2.1 C. R. Bard, Inc., Australia, Category Revenue Share (2011) 54
10.2.2 C. R. Bard, Inc., China, Category Revenue Share (2011) 56
10.2.3 C. R. Bard, Inc., India, Category Revenue Share (2011) 58
10.2.4 C. R. Bard, Inc., Japan, Category Revenue Share (2011) 60
10.2.5 C. R. Bard, Inc., Other Asia-Pacific, Category Revenue Share (2011) 62
10.3 C. R. Bard, Inc., Europe, Category Revenue Share (2011) 64
10.3.1 C. R. Bard, Inc., France, Category Revenue Share (2011) 66
10.3.2 C. R. Bard, Inc., Germany, Category Revenue Share (2011) 68
10.3.3 C. R. Bard, Inc., Italy, Category Revenue Share (2011) 70
10.3.4 C. R. Bard, Inc., Spain, Category Revenue Share (2011) 72
10.3.5 C. R. Bard, Inc., United Kingdom, Category Revenue Share (2011) 74
10.3.6 C. R. Bard, Inc., Other Europe, Category Revenue Share (2011) 76
10.4 C. R. Bard, Inc., Middle East and Africa, Category Revenue Share (2011) 78
10.5 C. R. Bard, Inc., North America, Category Revenue Share (2011) 80
10.5.1 C. R. Bard, Inc., Canada, Category Revenue Share (2011) 82
10.5.2 C. R. Bard, Inc., United States, Category Revenue Share (2011) 84
10.6 C. R. Bard, Inc., South and Central America, Category Revenue Share (2011) 86
10.6.1 C. R. Bard, Inc., Brazil, Category Revenue Share (2011) 88
10.6.2 C. R. Bard, Inc., Other South and Central America, Category Revenue Share (2011) 90
11 Key Employees 92
12 Key Employee Biographies 93
13 Company Statement 94
14 Locations And Subsidiaries 97
14.1 Head Office 97
14.2 Other Locations & Subsidiaries 97
15 Financial Deals Landscape 101
15.1 C. R. Bard, Inc., Deals Volume Summary, 2007 to 2012 101
16 C. R. Bard, Inc. Detailed Deal Summary 103
16.1 Asset Purchase 103
16.1.1 PacerView Technologies Sells PacerView Technology To Bard Access Systems 103
16.1.2 Spire Completes Sale Of Hemodialysis Catheter Business To Bard Access Systems For $12.5 Million 104
16.1.3 Davol Acquires XenMatrix From Brennen Medical For $17 Million 106
16.1.4 Edwards Lifesciences Sells LifeStent Product Line Assets To C. R. Bard For $140 Million 107
16.1.5 C. R. Bard Acquires Assets From Inrad 109
16.1.6 C. R. Bard Acquires EasyTac From Agency for Medical Innovations 110
16.2 Venture Financing 111
16.2.1 NeoMend Secures $10 Million In Financing 111
16.2.2 Lutonix Secures $10 Million In Series C Financing 112
16.2.3 Neomend Raises $33 Million In Venture Financing 113
16.2.4 NeoMend Secures $30 Million In Series D Financing Round 115
16.2.5 Medivance Secures $8 Million In New Venture Financing Round 117
16.2.6 Lutonix Secures $20 Million In Series B Financing 118
16.2.7 NeoMend Secures An Additional $15 Million In Series C Financing 119
16.2.8 FlowCardia Raises $30 Million In Series C Financing 120
16.2.9 NeoMend Secures $10.02 Million In Series C Funding 122
16.2.10 Lutonix Secures $5 Million In Series A Financing 123
16.3 Private Equity 124
16.3.1 Protostar Equity Partners Acquires Minority Stake In SenoRx 124
16.4 Partnerships 125
16.4.1 Covalon Technologies Expands Agreement With C. R. Bard 125
16.4.2 Covalon Technologies Signs Licensing Agreement With C. R. Bard 126
16.4.3 ClearStream Technologies Enters Into Licensing Agreement With C. R. Bard 127
16.4.4 C. R. Bard Signs Licensing Agreement With Genzyme 128
16.4.5 TyRx Pharma Enters Into Licensing Agreement With C. R. Bard 129
16.4.6 RTI Biologics Expands Distribution Agreement With Davol For Tutoplast Sterilized Dermal Allografts 130
16.4.7 Terason Ultrasound Enters Into Technology Integration Agreement With SenoRx 131
16.4.8 Medegen Signs An Agreement With C. R. Bard 132
16.4.9 IDev Technologies Enters Into A Distribution Agreement With YMed 133
16.4.10 Maelor Enters Into Distribution Agreement With Bard Limited 134
16.4.11 Cordis Enters Into Distribution Agreement With ClearStream Technologies 135
16.5 Equity Offering 136
16.5.1 ClearStream Technologies Completes Private Placement For $2 Million 136
16.5.2 ClearStream Technologies Completes Private Placement Of $5.6 Million 137
16.5.3 ClearStream Technologies Completes Private Placement Of $0.92 Million 138
16.5.4 ClearStream Technologies Completes Private Placement Of $1.8 Million 139
16.5.5 SenoRx Completes IPO Of $50.6 Million 140
16.5.6 C. R. Bard Completes Public Offering Of Senior Unsecured Notes Due 2016 For $250 Million 141
16.5.7 C. R. Bard Completes Public Offering Of Senior Unsecured Notes Due 2021 For $500 Million 143
16.6 Acquisition 145
16.6.1 C. R. Bard Acquires Lutonix 145
16.6.2 C. R. Bard Completes Acquisition Of Medivance For $250 Million 146
16.6.3 C. R. Bard Completes Acquisition Of Clearstream Technologies For $69 Million 148
16.6.4 C. R. Bard Completes Acquisition Of SenoRx For $213 Million 150
16.6.5 C.R. Bard Acquires Remaining 15% Stake In Bard Sendirian For $26 Million 152
16.6.6 C. R. Bard Completes Acquisition Of FlowCardia For $80.1 Million 153
16.6.7 C. R. Bard Acquires Y-Med For $35.3 Million 155
16.6.8 C. R. Bard Acquires Specialized Health Products International For $68 Million 156
17 Recent Developments 158
17.1 Strategy And Business Planning 158
17.1.1 May 10, 2012: C R Bard Creates 200 New Jobs Through Puerto Rican Expansion 158
17.1.2 Dec 13, 2010: Bard To Improve Overall Cost Structure And Enhance Operational Effectiveness 158
17.2 Financial Announcements 159
17.2.1 Jan 31, 2013: Bard Reports Revenue Of $3 Billion In 2012 159
17.2.2 Oct 23, 2012: Bard Reports Revenue Of $722.9m In Q3 2012 160
17.2.3 Jul 25, 2012: Bard Reports Revenue Of $742.6m In Q2 2012 160
17.2.4 Apr 24, 2012: Bard Reports Revenue Of $730m In Q1 2012 160
17.2.5 Jan 31, 2012: Bard Reports Revenue Of $2.9 Billion In 2011 161
17.2.6 Oct 25, 2011: Bard Reports Revenues Of $719.2m In Q3 2011 161
17.2.7 Jul 21, 2011: Bard Reports Net Sales Of $725m In Q2 2011 162
17.2.8 Apr 21, 2011: Bard Reports Net Sales Of $700.3m In Q1 2011 162
17.2.9 Jan 31, 2011: Bard Reports Net Sales of $2.72 Billion In 2010 163
17.2.10 Oct 21, 2010: Bard Reports Net Income Of $127.50 Million In Q3 2010 163
17.2.11 Jul 22, 2010: Bard Reports Net Income Of $124.7 Million For Q2 2010 164
17.2.12 Apr 22, 2010: Bard Reports Net Income Of $121.2 Million In Q1 2010 164
17.2.13 Jan 28, 2010: Bard Reports Net Income Of $461.4 Million In 2009 165
17.2.14 Oct 21, 2009: C.R. Bard Reports Net Income Of $130 Million In Q3 2009 165
17.2.15 Jul 22, 2009: Bard Posts Net Income Of $112.2 Million For Q2 2009 166
17.2.16 Jul 22, 2009: CR Bard Q2 Net Income Up 44% 166
17.2.17 Apr 22, 2009: Bard Posts Net Income Of $112.5 Million For Q1 2009 167
17.2.18 Jan 29, 2009: Bard Reports 2008 Results 167
17.2.19 Dec 10, 2008: Bard Reports Quarterly Dividend 168
17.2.20 Oct 22, 2008: Bard Reports 3Q 2008 Results 168
17.2.21 Oct 15, 2008: Bard To Declare 3Q 2008 Results 168
17.2.22 Oct 08, 2008: Bard Reports Quarterly Dividend 168
17.2.23 Jul 23, 2008: Bard Declares 2Q 2008 Results 169
17.2.24 Jun 11, 2008: Bard Reports Quarterly Dividend 169
17.2.25 Apr 23, 2008: Bard Reports Q1 2008 Results 170
17.2.26 Apr 16, 2008: Bard Reports Quarterly Dividend 170
17.2.27 Apr 15, 2008: Bard To Declare Q1 2008 Results 170
17.2.28 Jan 31, 2008: Bard Reports Q4 2007 Results 171
17.2.29 Dec 12, 2007: Bard Declares Quarterly Dividend 171
17.2.30 Oct 23, 2007: Bard Reports Q3 2007 Results 172
17.2.31 Oct 10, 2007: Bard Declares Quarterly Dividend 173
17.2.32 Oct 10, 2007: Bard Announces Share Repurchase Program 173
17.2.33 Jul 24, 2007: Bard Reports Q2 2007 Results 173
17.2.34 Jun 13, 2007: Bard Declares Quarterly Dividend 174
17.2.35 Apr 24, 2007: Bard Reports Q1 2007 Results 174
17.2.36 Apr 18, 2007: Bard Declares Quarterly Dividend 175
17.2.37 Jan 25, 2007: Bard Reports Q4 2006 Results 175
17.3 Corporate Communications 177
17.3.1 Nov 26, 2012: C.R. Bard To Lay Off 54 Workers From Queensbury Plant 177
17.3.2 Apr 30, 2012: C R Bard Appoints Christopher S Holland As CFO 177
17.3.3 Dec 02, 2011: C.R. Bard Plans To Cut 50 Jobs From Queensbury Plant 177
17.3.4 Aug 01, 2011: Bard Announces Retirement Of Todd Schermerhorn As Senior Vice President And CFO 178
17.3.5 Feb 10, 2011: C.R. Bard To Cut 200 Jobs From Queensbury Plant 178
17.3.6 Feb 10, 2011: Bard Appoints Todd Garner As Vice President, Investor Relations 178
17.3.7 Feb 10, 2011: C. R. Bard To Reduce Workforce By 20% 179
17.3.8 Apr 13, 2009: Bard Announces Promotion Of Jim C. Beasley To Group Vice President 179
17.3.9 Jun 25, 2008: Bard Announces Executive Promotion 179
17.4 Legal and Regulatory 180
17.4.1 Jan 15, 2013: C R Bard Wins Round As Supreme Court Rejects Gore Patent Appeal 180
17.4.2 Aug 06, 2012: Jury Returns $5.5m Verdict Against C.R. Bard In Transvaginal Mesh Lawsuit 180
17.4.3 Jul 06, 2011: C.R. Bard Extends Settlement In Kugel Mesh Litigation 181
17.4.4 Aug 18, 2010: Atrium Responds To Bard Suit 181
17.4.5 Mar 11, 2010: FDA Issues Warning On Counterfeit Surgical Mesh 182
17.4.6 Sep 29, 2009: Bard Gets Favorable Ruling In Class Action Lawsuit 183
17.4.7 Jul 30, 2008: US District Court Rules In Favor Of Bard On Patent Violation Suit Against Gore 183
17.5 Product News 183
17.5.1 Nov 02, 2012: C. R. Bard Receives FDA 510(k) Approval For Ajust Helical Adjustable Single Incision Sling 183
17.5.2 Jul 27, 2012: Bard Announces Enrollment Completion Of Lutonix Drug-Coated Balloon Clinical Trial And Initiation Of Large Continuation Registry Study 184
17.5.3 Jul 25, 2012: Bard Announces Enrollment Completion Of Lutonix Drug-Coated Balloon Clinical Trial And Initiation Of Large Continuation Registry Study 184
17.5.4 Jun 15, 2010: C.R. Bard Announces Publication Of RESILIENT Trial Results Of Bard LIFESTENT Vascular Stent 185
17.5.5 Feb 16, 2010: C.R. Bard To Complete Clinical Trial For Bard Ventrio Hernia Patch In First Half Of 2011 186
17.5.6 Sep 08, 2009: Bard To Complete Phase I Trial For RESTORe Suturing System In Second Half Of 2010 186
17.5.7 Sep 02, 2009: Bard To Complete The Phase III Trial For BARD HD MESH Ablation System In First Half Of 2011 186
17.5.8 Jul 22, 2009: C.R. Bard Plans To Introduce Ultraverse.018 Balloon 187
17.5.9 Jul 22, 2009: C.R. Bard Plans To Launch .014 Ultra Low Profile Balloon 187
17.5.10 Jul 22, 2009: C.R. Bard Plans To Launch LifeStent Product Enhancements 187
17.5.11 Feb 17, 2009: C. R. Bard Receives US FDA Approval To Market LifeStent FlexStar Vascular Stent Systems 187
17.5.12 Dec 08, 2008: Bard Receives FDA Approval For The E-Luminexx Vascular Stent 188
17.5.13 Aug 20, 2008: C. R. Bard Inc. Published Clinical Study Results Of Agento I.C. Silver-Coated Endotracheal Tube 188
17.5.14 Nov 08, 2007: Bard Receives Clearance To Market Agento IC Silver-Coated Endotracheal Tube 188
17.6 Product Approvals 189
17.6.1 Nov 02, 2012: C. R. Bard Receives FDA 510(k) Approval For Ajust Helical Adjustable Single Incision Sling 189
17.6.2 Feb 17, 2009: C. R. Bard Receives US FDA Approval To Market LifeStent FlexStar Vascular Stent Systems 189
17.6.3 Dec 08, 2008: Bard Receives FDA Approval For The E-Luminexx Vascular Stent 190
17.6.4 Nov 08, 2007: Bard Receives Clearance To Market Agento IC Silver-Coated Endotracheal Tube 190
17.7 Clinical Trials 191
17.7.1 Jul 27, 2012: Bard Announces Enrollment Completion Of Lutonix Drug-Coated Balloon Clinical Trial And Initiation Of Large Continuation Registry Study 191
17.7.2 Jul 25, 2012: Bard Announces Enrollment Completion Of Lutonix Drug-Coated Balloon Clinical Trial And Initiation Of Large Continuation Registry Study 191
17.7.3 Jun 15, 2010: C.R. Bard Announces Publication Of RESILIENT Trial Results Of Bard LIFESTENT Vascular Stent 192
17.7.4 Feb 16, 2010: C.R. Bard To Complete Clinical Trial For Bard Ventrio Hernia Patch In First Half Of 2011 193
17.7.5 Sep 08, 2009: Bard To Complete Phase I Trial For RESTORe Suturing System In Second Half Of 2010 193
17.7.6 Sep 02, 2009: Bard To Complete The Phase III Trial For BARD HD MESH Ablation System In First Half Of 2011 194
17.7.7 Aug 20, 2008: C. R. Bard Inc. Published Clinical Study Results Of Agento I.C. Silver-Coated Endotracheal Tube 194
17.8 Other Significant Developments 195
17.8.1 Nov 28, 2012: Novation Awards Cardiovascular Agreements 195
17.8.2 Aug 15, 2012: Hospitals, Healthcare Providers To Benefit From New Premier Agreements For Wound Drainage Products 195
17.8.3 Mar 01, 2012: Hospitals, Healthcare Providers To Benefit From New Premier Agreements For Invasive Cardiology Equipment 195
17.8.4 Nov 14, 2011: Hospitals, Healthcare Providers To Benefit From New Premier Agreements For Electrophysiology Products 195
18 Appendix 196
18.1 Research Methodology 197
18.2 Secondary Research 197
18.3 Primary Research 197
18.4 Models 198
18.5 Forecasts 198
18.6 Expert Panels 198
18.7 GlobalData Consulting 198
18.8 Currency Conversion 199
18.9 Contact Us 200
18.10 Disclaimer 200


【レポート販売概要】

■ タイトル:C. R. Bard, Inc.:市場シェア分析
■ 英文:C. R. Bard, Inc. Market Share Analysis
■ 発行日:2013年2月28日
■ 調査会社:GlobalData
■ 商品コード:GDATA403160482
■ 調査対象地域:グローバル
  • 熱障壁コーティング(TBC)の世界市場分析:製品別(金属、セラミック、金属間化合物)、技術別(EB-PVD、HVOF、CVD、エアプラズマ)、コーティングコンビネーション別(セラミックYSZ、Al 2 O 3、MCrAlY、ムライトベース)、用途別(固定発電所、航空宇宙、自動車)、セグメント予測
    The global thermal barrier coatings market is expected to reach a market size of USD 22.30 billion by 2024, according to a new report by Grand View Research, Inc. The industry is expected to witness significant growth over the forecast period owing to the increased adoption of air plasma and vapor deposition technologies for coating application, thereby increasing the demand from various applicati …
  • 世界のテキスト分析(Text Analytics)市場動向(2014-2019)
    Today, the industries and organizations have become acquainted about the importance of text analytics in brand and reputation management and for achieving customer satisfaction. Text analytics software is equipped to handle any size and form of data with complex algorithms. Text analytics has evolved from a theoretical approach to a more tactical approach. Customer retention through brand building …
  • 糖尿病網膜症治療薬の世界市場2015-2019
    About Diabetic Retinopathy Diabetic retinopathy is a disorder of the eye that damages the blood vessels of the retina. The retina is the light-sensitive inner surface of the eye on which images are formed. Long-term diabetes affects the retina as high blood glucose levels can damage the tiny blood vessels in the retina. Diabetic retinopathy is broadly classified into non-proliferative diabetic ret …
  • セルフペース型eラーニングの世界市場2016-2020
    About the Generic E-Learning Courses Market E-learning refers to learning through electronic gadgets, such as PCs, notebooks, and tablets. It is backed by ICT that enables users to learn 24/7 learning from any access point. The curriculum of e-learning includes archived and real-time information. There is no set standard of e-learning method used in the education market. Differentiation is primari …
  • データセンター用サーバーの世界市場2017-2021
    About Data Center Server Servers are the backbone of a data center operation, and they are used mainly for the transfer of data over computer networks. A server operation is dependent on hardware reliability and durability. A typical server consists of dual-power supplies, redundant array of independent disks (RAID) disk systems, and error-correcting code (ECC) memory, which are tested for operati …
  • 世界の自動車伝送制御装置市場動向(2012-2016)
    TechNavio's analysts forecast the Global Automotive Transmission Control Unit market to grow at a CAGR of 5.54 percent over the period 2012-2016. One of the key factors contributing to this market growth is stringent fuel efficiency standards. The market has also been witnessing growth opportunities in emerging countries. However, high cost of transmission control units could pose a challenge to t …
  • 医療オートメーションの世界市場:診断/モニタリング、治療、ラボ/薬局、物流、トレーニング
    On the basis of application, the medical automation market is divided into four segments, namely, diagnostic and monitoring automation (automated image analysis, automated imaging, and point-of-care testing), therapeutic automation (non-surgical automation and surgical automation), laboratory and pharmacy automation (laboratory automation and pharmacy automation), and medical logistics and trainin …
  • Machine-to-Machine (M2M) and RFID
    Machine-to-Machine (M2M) communications and Radio Frequency ID (RFID) together represent a means of direct communication between connection hardware and the object that needs monitoring: the information about its status of performance is directly sent to a computer system without the need for human intervention. This makes automation of processes or consumer action possible. The technology that ut …
  • ビデオサービスの世界市場:VOD、ビデオ配信
    About Video Services Video services refer to the VOD and video streaming services offered by digital content providers. VOD services allow users to access video content on demand either through streaming services or over-the-top (OTT) video services. The revenue is realized from the fee earned by VOD service providers through advertisements, subscriptions, and DTO services. Viewers can sign up for …
  • 電力&配電変圧器の世界市場2016-2026
    Visiongain calculates the global power and distribution transformers market to be worth $34.998bn in 2016. Power and distribution transformer investment is aligned to power T&D infrastructure developments and increases in power network coverage. More efficient transformers are required to reduce power losses and cater for the increasing voltages of long-distance transmission. For local application …
  • ピザの世界市場2016-2020
    About Pizza Over the years, people worldwide have developed a special craving for pizza, both at home as well as at restaurants. Pizza is the amalgamation of varied parts: crust, vegetables, cheese, sauce, meat or other proteins, and the baking style. All these are vital, but the toppings are the most indispensable ingredient that provides an opportunity to pizza manufacturers to introduce new and …
  • 抗体薬物複合体の世界市場及びパイプライン分析
    Pharmaceutical companies are trying to develop better therapeutics in order to overcome large unmet medical necessities. Currently available therapeutics suffers from various caveats like low specificity, low potency and severe adverse effects. This scenario has caused the pharmaceutical companies to develop therapeutics that can succeed these limitations. They have been able to overcome these pro …
  • Associated Electric Cooperative Inc.:発電所及びSWOT分析2013
    Associated Electric Cooperative Inc. - Power Plants and SWOT Analysis, 2013 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (executives), and major products and services. Scope - Major Power Plants (assets) …
  • 世界におけるラグジュアリー製品のネット通販市場:個人用高級品、高級食品/ワイン、高級アクセサリー
    Luxury e-tailing involves the sales of luxury items from a vendor or retailer to a customer using the online medium. With the rapidly changing market dynamics, vendors are required to adapt to customers' tastes. Many brick-and-mortar retailers offer multichannel retailing so that shoppers also have the option of placing orders conveniently online. This has given rise to e-retailers, including vend …
  • 世界の対IED防衛市場動向2013-2023:地域別分析
    "The Global Counter IED Market 2012-2022 - Country Analysis: Market Profile" provides details of the key markets in each region, offering an analysis of the top segments of Counter IED, expected to be in demand. It also investigates the top three expected Counter IED programs, in terms of demand in the key markets in each region.
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。